A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard

Active, not recruiting

• Conditions: Hepatocellular Carcinoma

• Registration Number: NCT06748755
• Lead Sponsor: Superior University

Brief Summary

The study aims to evaluate the accuracy of ultrasound in diagnosing hepatocellular carcinoma (HCC), using histopathology as the gold standard. It addresses HCC's high global incidence and the utility of ultrasound as a non-invasive, cost-effective screening tool. Despite ultrasound's accessibility, its diagnostic limitations necessitate further investigation to improve clinical outcomes.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-03-01
• Primary Completion: 2024-09-01
• Status Verified: 2024-12
• Study First Submitted: 2024-12-19
• Study First Submitted QC: 2024-12-19
• Last Update Submitted: 2024-12-19
• Study First Posted: 2024-12-27
• Last Update Posted: 2024-12-27
• Study Completion: 2025-02-20

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Clinically suspected liver cancer patients undergoing ultrasound examination.
• Patients undergoing histopathological examination (liver biopsy or resection) for definitive diagnosis.

Exclusion Criteria

• Patients with history of liver cancer treatment or inadequate data."

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ultrasound	12 Months	Sensitivity and Specificity analysis of Ultrasound as diagnostic tool, with histopathology as gold standard.

Trial Locations

Locations (1)

Medcare International Hospital; 🇵🇰 Gujrānwāla, Punjab, Pakistan